Kaleido Biosciences (Kaleido Biosciences) EV-to-EBITDA

Kaleido Biosciences Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21
EV-to-EBITDA			-	-	-1.20	-3.93	-1.00

Kaleido Biosciences Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21
EV-to-EBITDA															-3.93	-3.40	-3.13	-2.34	-1.00

For the Biotechnology subindustry, Kaleido Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

For the Biotechnology industry and Healthcare sector, Kaleido Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Kaleido Biosciences's EV-to-EBITDA falls into.

Kaleido Biosciences EV-to-EBITDA Calculation

Kaleido Biosciences's EV-to-EBITDA for today is calculated as:

Kaleido Biosciences's current Enterprise Value is $-16.78 Mil.
Kaleido Biosciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-85.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kaleido Biosciences  (OTCPK:KLDO) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Kaleido Biosciences's PE Ratio for today is calculated as:

Kaleido Biosciences's share price for today is $0.0001.
Kaleido Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.160.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Kaleido Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Kaleido Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Kaleido Biosciences (Kaleido Biosciences) Business Description